2 ms·
It sounds like the ascertainment bias there will be improved as time passes: > Weaknesses of the present study include exclusive reliance on the National Patie
by gwern 11y ago
It sounds like the ascertainment bias there will be improved as time passes:
> Weaknesses of the present study include exclusive reliance on the National Patient Register for case ascertainment, leading to a selected and perhaps severely affected sample by only including individuals with ASD who had been in contact with clinical psychiatry services. This selection bias may be particularly relevant for individuals diagnosed before the year 2001 (i.e. before contact with out-patient psychiatric care services was included in the National Patient Register). However, after the year 2001 (88.2% in current data) all individuals having received an ASD diagnosis are registered in the National Patient Register because of the diagnostic assessment per se, i.e. also in cases with no further contact with psychiatric services.
Another way around this would be genotyping: use an autism polygenic score to quantify genetic liability. If the increased mortality is observed even with elevated polygenic scores which are insufficient to lead to diagnosable symptoms, that would suggest the cause is greater general genetic risk to disease rather than sequelae to symptoms.
- tim333 11y agoI wonder how the mortality for people diagnosed with ASD compares with the mortality for people diagnosed with anything by a psychiatrist. It seems likely that by the time people see psychiatrists they're already on average less healthy than the general population.